Healio (6/30, Young) reported, “Existing treatments for patients with an ultrahigh risk of psychosis offer relatively poor responsiveness, underscoring a need for further innovation in relapse prevention,” researchers concluded in the findings of a 342-participant study published online June 28 in JAMA Psychiatry.
Related Links:
— “Innovation needed in relapse prevention for those with ultrahigh risk of psychosis,” Healio, June 30, 2023